Alzheimer's Disease Research Center in the News

News from the Memory and Brain Wellness Center

September 02, 2024

Life’s Tapestry

Preserving memories through a conversation game

Read More

Categories: Community Stories, Dimensions 2024, Art, Dementia-Friendly Community


Discoveries Made Possible By You // Fall 2024

For these studies, researchers used data from participants in the UW ADRC Clinical Core, with gratitude.

Read More

Categories: Science Updates, Dimensions 2024


Dr. Swati Rane Levendovszky’s Brain Imaging Approach to Studying the Brain’s Blood Vessels and Alzheimer’s Disease

Swati Rane Levendovszky, PhD, an associate professor of radiology at the University of Washington, explores blood vessel pathology and its relation to Alzheimer’s disease in the living brain using brain imaging. Her work on UW, national, and worldwide research projects has propelled her to new levels of leadership in the UW Alzheimer's Disease Research Center.

Read More

Categories: Science Updates, Team Spotlights, Dimensions 2024, Brain Health Awareness


August 30, 2024

Dementia Friends play a part in building dementia-friendly communities in eastern Washington

Aging and Long Term Care of Eastern Washington, an agency that covers Ferry, Pend Oreille, Spokane, Stevens, and Whitman counties, has been seeing positive growth in the Dementia Friends program, as well as increased volunteer interest.

Read More

Categories: Community Stories, Resources, Dementia Friends, Dementia-Friendly Community


August 29, 2024

Dimensions Magazine Summer // Fall 2024

Enjoy the latest issue of Dimensions Magazine! Find inside the latest findings in Alzheimer's and brain health research, a faculty spotlight, and a new conversation game meant to preserve memories and legacy, and so much more.

Read More

Categories: Science Updates, Care & Treatment , Team Spotlights, Community Stories, Caregiving, Resources, Brain Health, Dementia-Friendly Community


August 05, 2024

¿Como decidió participar?

Dos hermanas nos comparten su conmovedora historia sobre su participación en un estudio clínico sobre la enfermedad de Alzheimer / Two sisters share their moving story about participating in a clinical study on Alzheimer's disease at the UW ADRC.

Read More

Categories: Community Stories, En Español


July 30, 2024

New Recommendations to Reduce Dementia Risk Worldwide; Untreated High Cholesterol and Vision Loss Linked to Raised Risk

The Commission is authored by 27 dementia experts, including the UW ADRC’s Eric B. Larson, MD, MPH, who is affiliate professor of medicine in the UW School of Medicine, who has now worked on all three Lancet reports that make recommendations for policy makers and individuals to help reduce dementia risk worldwide. Larson gives us context for the new recommendations and shares how UW research has influenced this report.

Read More

Categories: Science Updates, Care & Treatment , Brain Health Awareness


July 22, 2024

My Experience Caring for My Wife Gail and What I Learned About Communication and Alzheimer’s.

I was the caregiver for my late wife Gail over the last five years of her life. I hope to share my experience with other caregivers and relate how changing my way of communicating helped us.

Read More

Categories: Community Stories, Caregiving, Dimensions 2024, Nature


July 15, 2024

Remembering Our Research Colleague, Will Affleck-Asch

It is with great sadness and regret that University of Washington (UW) ADRC announces the passing of our dear colleague Will Affleck-Asch. Will joined the UW ADRC Data, Methods, and Statistics core in 2006, and has since been an instrumental force for implementation of rigorous data management and quality control techniques within our Center. Will was a consistent, passionate, clear voice for reason and logic, always working towards the betterment of the whole, even through his last days with us.

Read More

Categories: Community Stories


July 08, 2024

FDA approves Alzheimer’s drug donanemab

"Donanemab's compelling clinical trial outcome not only confirms that this treatment strategy is effective in treating Alzheimer's disease, but also provides clinicians additional opportunities to tailor the amyloid monoclonal antibody to the individual patient," said MBWC Clinical Trials Director, Michael Rosenbloom, MD

Read More

Categories: Science Updates, New FDA Drug Approvals